Ray Dalio Alkermes Plc. Transaction History

Bridgewater Associates, LP

  • $17.3 Billion
  • Q3 2024

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
SELL
$26.4 - $32.56 $886,617 - $1.09 Million
-33,584 Reduced 81.94%
7,400 $200,000
Q4 2023

Feb 14, 2024
BUY
$23.37 - $28.68 $188,899 - $231,820
8,083 Added 24.57%
40,984 $1.14 Million
Q3 2023

Nov 13, 2023
SELL
$27.17 - $31.97 $37,141 - $43,702
-1,367 Reduced 3.99%
32,901 $921,000
Q2 2023

Aug 11, 2023
SELL
$28.34 - $33.63 $6,319 - $7,499
-223 Reduced 0.65%
34,268 $1.07 Million
Q1 2023

May 12, 2023
SELL
$25.31 - $29.02 $153,024 - $175,454
-6,046 Reduced 14.91%
34,491 $972,000
Q4 2022

Feb 13, 2023
BUY
$21.94 - $26.24 $270,103 - $323,040
12,311 Added 43.62%
40,537 $1.06 Million
Q3 2022

Nov 10, 2022
SELL
$22.0 - $31.87 $31,394 - $45,478
-1,427 Reduced 4.81%
28,226 $630,000
Q2 2022

Aug 11, 2022
BUY
$26.4 - $30.54 $53,882 - $62,332
2,041 Added 7.39%
29,653 $883,000
Q1 2022

May 13, 2022
BUY
$23.07 - $27.99 $191,019 - $231,757
8,280 Added 42.83%
27,612 $726,000
Q4 2021

Feb 14, 2022
BUY
$21.47 - $32.08 $52,580 - $78,563
2,449 Added 14.51%
19,332 $450,000
Q3 2021

Nov 12, 2021
BUY
$23.37 - $32.13 $13,764 - $18,924
589 Added 3.61%
16,883 $521,000
Q2 2021

Aug 13, 2021
BUY
$18.78 - $25.15 $306,001 - $409,794
16,294 New
16,294 $400,000

Others Institutions Holding ALKS

# of Institutions
361
Shares Held
181M
Call Options Held
175K
Put Options Held
96.6K
View Full List

About Alkermes plc.

ALKS Quotes by TradingView
  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.73B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track Ray Dalio's Portfolio

Track Ray Dalio Portfolio

Follow Ray Dalio (Bridgewater Associates, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgewater Associates, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bridgewater Associates, LP and Ray Dalio with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email